QUSVM
Qiming U.S. Ventures Management’s Tourmaline Bio TRML Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.9M | Hold |
741,691
| – | – | 50.22% | 1 |
|
|
2025
Q1 | $11.3M | Hold |
741,691
| – | – | 48.83% | 1 |
|
|
2024
Q4 | $15M | Hold |
741,691
| – | – | 29.41% | 2 |
|
|
2024
Q3 | $19.1M | Hold |
741,691
| – | – | 37.12% | 1 |
|
|
2024
Q2 | $9.54M | Hold |
741,691
| – | – | 18.13% | 3 |
|
|
2024
Q1 | $17M | Buy |
741,691
+100,000
| +16% | +$2.29M | 18.94% | 3 |
|
|
2023
Q4 | $16.8M | Sell |
641,691
-2,290,915
| -78% | -$60M | 15.38% | 3 |
|
|
2023
Q3 | $8.24M | Hold |
2,932,606
| – | – | 10.94% | 3 |
|
|
2023
Q2 | $8.92M | Hold |
2,932,606
| – | – | 9.37% | 5 |
|
|
2023
Q1 | $5.51M | Hold |
2,932,606
| – | – | 6.67% | 5 |
|
|
2022
Q4 | $2.99M | Hold |
2,932,606
| – | – | 3.96% | 5 |
|
|
2022
Q3 | $7.71M | Hold |
2,932,606
| – | – | 11.2% | 4 |
|
|
2022
Q2 | $13.2M | Hold |
2,932,606
| – | – | 18.36% | 2 |
|
|
2022
Q1 | $28.9M | Hold |
2,932,606
| – | – | 27.11% | 1 |
|
|
2021
Q4 | $44.8M | Buy |
+2,932,606
| New | +$44.8M | 20.63% | 3 |
|